Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FVBG8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,073
Award facts
- Contract value 100% obligated
- $44,073.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors with a ceiling value of $44,073.31. This firm fixed-price delivery order, with an ultimate completion date of June 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open competition.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its role as a prime vendor supplying a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Zepbound, a diabetes medication, exemplifies the company's ongoing support of the Defense Health Agency and broader military healthcare programs through the DLA's global pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FVBG8?
SPE2DB25FVBG8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FVBG8 worth?
The government has obligated $44,073 on SPE2DB25FVBG8.
Is contract SPE2DB25FVBG8 an order under another contract?
Yes. SPE2DB25FVBG8 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVBG8 competed?
The extent of competition for SPE2DB25FVBG8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award